| Ident. | Authors (with country if any) | Title |
|---|
| 000074 (2017) |
Sebastien S. Prat [Canada] ; Bruno J. Losier [Canada] ; Heather M. Moulden [Canada] ; Gary A. Chaimowitz [Canada] | Incapacity of the Mind Secondary to Medication Misuse as a Not Criminally Responsible Defense. |
| 000180 (2016) |
Daniel J. Cameron [Canada] ; Kristen A. Pickett [États-Unis] ; Gammon M. Earhart [États-Unis] ; Jessica A. Grahn [Canada] | The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson’s Disease |
| 000191 (2016) |
Jean-François Daneault [Canada] ; Benoit Carignan [Canada] ; Abbas F. Sadikot [Canada] ; Christian Duval [Canada] | Subthalamic deep brain stimulation and dopaminergic medication in Parkinson's disease: Impact on inter-limb coupling. |
| 000382 (2016) |
Monika Bolina ; C. Allyson Jones ; Sheri Koshman ; Erin Heintz ; Cheryl A. Sadowski | Documentation of Functional Medication Management in Older Adults: A Retrospective Chart Review in Acute Care Hospitalization |
| 000581 (2015) |
Alberto J. Espay ; Matthew M. Norris ; James C. Eliassen ; Alok Dwivedi ; Matthew S. Smith ; Christi Banks ; Jane B. Allendorfer ; Anthony E. Lang ; David E. Fleck ; Michael J. Linke ; Jerzy P. Szaflarski | Placebo effect of medication cost in Parkinson disease |
| 000867 (2014) |
Fariborz Rahimi [Iran] ; Carina Bee [Canada] ; Christian Duval [Canada] ; Patrick Boissy [Canada] ; Roderick Edwards [Canada] ; Mandar Jog [Canada] | Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease. |
| 000904 (2014) |
Magda Osman [Royaume-Uni] ; Agata Ryterska [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; Lingling Tu [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | The effects of dopaminergic medication on dynamic decision making in Parkinson's disease. |
| 000905 (2014) |
Julie Nantel [Canada] ; Helen Bronte-Stewart [États-Unis] | The effect of medication and the role of postural instability in different components of freezing of gait (FOG). |
| 000946 (2014) |
Tiago A. Mestre [Canada] ; Tiago Teodoro [Portugal] ; William Reginold [Canada] ; Julia Graf [Allemagne] ; Maike Kasten [Allemagne] ; Joanna Sale [Canada] ; Mateusz Zurowski [Canada] ; Janis Miyasaki [Canada] ; Joaquim J. Ferreira [Portugal] ; Connie Marras [Canada] | Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians. |
| 000991 (2014) |
Chizoba C. Umeh [États-Unis] ; Adriana Pérez [États-Unis] ; Erika F. Augustine [États-Unis] ; Rohit Dhall [États-Unis] ; Richard B. Dewey [États-Unis] ; Zoltan Mari [États-Unis] ; David K. Simon [États-Unis] ; Anne-Marie A. Wills [États-Unis] ; Chadwick W. Christine [États-Unis] ; Jay S. Schneider [États-Unis] ; Oksana Suchowersky [Canada] | No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial |
| 000A86 (2014) |
Andrew Vo [Canada] ; Nole M. Hiebert [Canada] ; Ken N. Seergobin [Canada] ; Stephanie Solcz [Canada] ; Allison Partridge [Canada] ; Penny A. Macdonald [Canada] | Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's disease. |
| 000B82 (2014) |
Magda Osman [Royaume-Uni] ; Agata Rytersk [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; LINGLING TU [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | The effects of dopaminergic medication on dynamic decision making in Parkinson's disease |
| 000D57 (2013) |
David Mongeon [Canada] ; Pierre Blanchet ; Julie Messier | Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations. |
| 001065 (2013) |
David Mongeon [Canada] ; Pierre Blanchet [Canada] ; Julie Messier [Canada] | Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations |
| 001234 (2012) |
Nicola J. Ray [Canada] ; Janis M. Miyasaki [Canada] ; Mateusz Zurowski [Canada] ; Ji Hyun Ko [Canada] ; Sang Soo Cho [Canada] ; Giovanna Pellecchia [Canada] ; Francesca Antonelli [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study |
| 001501 (2012) |
Chaim M. Bell [Canada] ; Stacey S. Brener [Canada] ; Rebecca Comrie [Canada] ; Geoffrey M. Anderson [Canada] ; Susan E. Bronskill [Canada] | Quality Measures for Medication Continuity in Long-Term Care Facilities, Using a Structured Panel Process |
| 001679 (2011) |
James K R. Stevenson [Canada] ; Pouria Talebifard ; Edna Ty ; Meeko M K. Oishi ; Martin J. Mckeown | Dyskinetic Parkinson's disease patients demonstrate motor abnormalities off medication. |
| 001860 (2011) |
Andreas Kupsch [Allemagne] ; Michele Tagliati [États-Unis] ; Marie Vidailhet [France] ; Tipu Aziz [Royaume-Uni] ; Paul Krack [France] ; Elena Moro [Canada] ; Joachim K. Krauss [Allemagne] | Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting |
| 001924 (2011) |
Meir Plotnik [Israël] ; Nir Giladi [Israël] ; Yaacov Dagan [Israël] ; Jeffery M. Hausdorff [Israël, États-Unis] | Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the "ON" medication state |
| 001952 (2011) |
James K. R. Stevenson [Canada] ; Pouria Talebifard [Canada] ; Edna Ty [Canada] ; Meeko M. K. Oishi [Canada, États-Unis] ; Martin J. Mckeown [Canada] | Dyskinetic Parkinson's disease patients demonstrate motor abnormalities off medication |
| 001E29 (2009) |
Thomas Jubault [Canada] ; Laura Monetta [Canada] ; Antonio P. Strafella [Canada] ; Anne-Louise Lafontaine [Canada] ; Oury Monchi [Canada] | L-Dopa Medication in Parkinson's Disease Restores Activity in the Motor Cortico-Striatal Loop but Does Not Modify the Cognitive Network |
